COMMUNIQUÉS West-GlobeNewswire

Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 06 April 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” [...]
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
06/04/2026
– Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments (managed by Yosemite), GV (Google Ventures), LoLa Capital [...]
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
06/04/2026
- Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment - - Strategic financing to accelerate development of earlier-stage gene therapy [...]
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WATERTOWN, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms [...]
Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High
06/04/2026
Record-breaking output validates aggressive scale-up strategy as Company accelerates toward 10 metric tons per month ANN ARBOR, Mich., April 06, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
MEDVi QUAD Claims Evaluated: Real Online Doctor-Approval ED Medication for Men's Sexual Performance
04/04/2026
4-in-1 compounded prescription erectile dysfunction treatment program details, sublingual delivery format, telehealth platform structure, FDA regulatory context, and consumer verification steps for men evaluating doctor [...]
BienRaíz Launches Premium D3 + K2 Formula for Bone Health and Heart Function
04/04/2026
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to reveal the critical relationship between vitamin D3 and vitamin K2, BienRaíz—a supplement brand committed to foundational wellness through nature and [...]
VigorX Pro Claims Evaluated: The VitalPro ManForceX Supplementation Method Working for Men Worldwide
04/04/2026
A 2026 informational release covering VigorX Pro's prostate health and male vitality claims, the VitalPro ManForceX supplementation method for men over 40, ingredient research context, pricing structure, 60-day [...]
Vireo Growth Inc. Partners with Ace Ventures to Establish New York’s First Minority-owned Vertically Integrated Medical Cannabis Operator
04/04/2026
Majority ownership of Vireo Health of New York to transfer to MWBE-led Ace Ventures; partnership reinforces long-term alignment with New York’s social equity framework MINNEAPOLIS, April 03, 2026 (GLOBE NEWSWIRE) -- [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/04/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
03/04/2026
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX ® ( [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer [...]
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune diseases, today [...]
Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale
03/04/2026
Blue Heron Health News Explains How Scott Davis's Overcoming Onychomycosis Gut-Health and Immune-Support Program Works, What the Digital Guide Includes, Who It May Be Designed For, and How Consumers Can Verify Current [...]
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
03/04/2026
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”) from the NYSE [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026
BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention [...]
Weight Watchers Announces Leadership Transition and Board Updates
03/04/2026
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” [...]
VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men
03/04/2026
A 2026 informational consumer overview of VitalRIZE's male enhancement and virility support positioning, ingredient research context, pricing structure, and what men over 45 should verify before purchasing Aurora, CO, [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/04/2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April 1, 2026, the Company [...]

Pages